Resources
Blog
Journalists

Log In
Sign Up
Data Privacy
Send a Release

News
Products
Contact

Search When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News in Focus
- Browse News Releases
  
  All News Releases
  
  All Public Company
  
  English-only
  
  News Releases Overview
  Multimedia Gallery
  
  All Multimedia
  
  All Photos
  
  All Videos
  
  Multimedia Gallery Overview
  Trending Topics
  
  All Trending Topics
Business & Money
Science & Tech
Lifestyle & Health
Policy & Public Interest
People & Culture
- - In-Language News
  - Arabic
  - español
  - português
  - Česko
  - Danmark
  - Deutschland
  - España
  - France
  - Italia
  - Nederland
  - Norge
  - Polska
  - Portugal
  - Россия
  - Slovensko
  - Suomi
  - Sverige

Overview
Distribution by PR Newswire
Cision Communications Cloud®
Cision IR
Sponsored Placement
All Products

General Inquiries
Request a Demo
Editorial Bureaus
Partnerships
Media Inquiries
Worldwide Offices

Send a Release
- ALL CONTACT INFO
- Contact Us
  
  888-776-0942
  from 8 AM - 10 PM ET

Send a Release
Sign Up
Log In
Resources
Blog
Journalists
RSS
GDPR

News in Focus
Business & Money
Science & Tech
Lifestyle & Health
Policy & Public Interest
People & Culture
- People & Culture
Send a Release
Sign Up
Log In
Resources
Blog
Journalists
RSS
GDPR

Overview
Distribution by PR Newswire
Cision Communications Cloud®
Cision IR
All Products
Send a Release
Sign Up
Log In
Resources
Blog
Journalists
RSS
GDPR

General Inquiries
Request a Demo
Editorial Bureaus
Partnerships
Media Inquiries
Worldwide Offices
Send a Release
Sign Up
Log In
Resources
Blog
Journalists
RSS
GDPR

Alfa Laval AB (publ) Interim Report July 1 - September 30, 2019

News provided by

Oct 24, 2019, 03:49 ET

Share this article

Share this article

Modal title

Also from this source

3Z: Zebrafish mutant model reveals novel drug candidates for ADHD

3Z: Zebrafish mutant model reveals novel drug candidates for ADHD

Explore

More news releases in similar topics

HVAC (Heating, Ventilation and Air-Conditioning)
Household, Consumer & Cosmetics
Oil & Energy
Utilities
Earnings

Contact Cision

Cision Distribution 888-776-0942
from 8 AM - 9 PM ET
Chat with an Expert

General Inquiries
Request a Demo
Editorial Bureaus
Partnerships
Media Inquiries
Worldwide Offices

Products

Cision Communication Cloud®
For Marketers
For Public Relations
For IR & Compliance
For Agency
For Small Business
All Products

About

About PR Newswire
About Cision
Become a Publishing Partner
Become a Channel Partner
Careers
COVID-19 Resources
Accessibility Statement

Asia
Brazil
Canada
Czech
Denmark
Finland
France
Germany
India
Israel
Italy
Mexico
Middle East
Middle East - Arabic
Netherlands
Norway
Poland
Portugal
Russia
Slovakia
Spain
Sweden
United Kingdom

My Services

All New Releases
Online Member Center
ProfNet

Contact Cision

Products

About

All News Releases
Online Member Center
ProfNet

Cision Distribution Helpline
888-776-0942

Terms of Use
Privacy Policy
Information Security Policy
Site Map
RSS
Cookie Settings

Copyright © 2023 Cision US Inc.